Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Outlook Therapeutics (OTLK) Preferred Dividend Payments (2016 - 2019)

Outlook Therapeutics has reported Preferred Dividend Payments over the past 5 years, most recently at $166133.0 for Q4 2019.

  • Quarterly Preferred Dividend Payments rose 10.38% to $166133.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $328214.0 through Jun 2020, down 47.63% year-over-year, with the annual reading at $166133.0 for FY2020, 73.42% down from the prior year.
  • Preferred Dividend Payments was $166133.0 for Q4 2019 at Outlook Therapeutics, up from $162081.0 in the prior quarter.
  • Over five years, Preferred Dividend Payments peaked at $1.1 million in Q2 2015 and troughed at -$1.9 million in Q3 2015.
  • The 5-year median for Preferred Dividend Payments is $166133.0 (2019), against an average of $294585.5.
  • Year-over-year, Preferred Dividend Payments skyrocketed 1423.54% in 2016 and then plummeted 75.77% in 2019.
  • A 5-year view of Preferred Dividend Payments shows it stood at $939539.0 in 2015, then tumbled by 47.51% to $493207.0 in 2016, then fell by 8.6% to $450801.0 in 2017, then tumbled by 66.61% to $150508.0 in 2018, then rose by 10.38% to $166133.0 in 2019.
  • Per Business Quant, the three most recent readings for OTLK's Preferred Dividend Payments are $166133.0 (Q4 2019), $162081.0 (Q3 2019), and $158128.0 (Q2 2019).